Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment
NCT00133848 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 210
Last updated 2016-09-23
Summary
The goal of this study is to determine if topical SB-275833 ointment, 1% is more effective than a placebo ointment in the treatment of primary impetigo.
Conditions
- Impetigo
Interventions
- DRUG
-
SB-275833 ointment, 1%
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 9 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-04-30
- Completion
- 2006-01-31
Countries
- India
- Italy
- Mexico
- Netherlands
- Peru
Study Locations
More Related Trials
-
Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications
NCT00964366 ·Status: COMPLETED ·Phase: PHASE4
-
Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis
NCT02337205 ·Status: COMPLETED ·Phase: PHASE1
-
A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp
NCT05231044 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne
NCT02322866 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash
NCT04697069 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne
NCT03709654 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy
NCT00849992 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
NCT01998984 ·Status: COMPLETED ·Phase: PHASE2
-
Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp
NCT02838628 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis
NCT04219358 ·Status: TERMINATED ·Phase: PHASE1
-
A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
NCT00700063 ·Status: COMPLETED ·Phase: PHASE2
-
To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis
NCT02385318 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand
NCT00544297 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis
NCT06135415 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.
NCT07318675 ·Status: RECRUITING ·Phase: PHASE1
-
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)
NCT03285490 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
NCT06108024 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis
NCT01214564 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash
NCT00891982 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea
NCT03050086 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
NCT00375739 ·Status: COMPLETED ·Phase: PHASE2
-
MC RCT - BPO vs Adapalene
NCT05536882 ·Status: WITHDRAWN ·Phase: PHASE3
-
Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo
NCT04192513 ·Status: TERMINATED ·Phase: PHASE2
-
Topical Gentamicin Nonsense Suppression Therapy of EB
NCT04644627 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
NCT07013201 ·Status: RECRUITING ·Phase: PHASE2